De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
McMillan Shakespeare Toekomstige groei
Future criteriumcontroles 2/6
McMillan Shakespeare zal naar verwachting groeien in winst en omzet met respectievelijk 5.3% en 2.1% per jaar. De winst per aandeel zal naar verwachting groeien met 5.3% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 83.2% zijn.
Belangrijke informatie
5.3%
Groei van de winst
5.3%
Groei van de winst per aandeel
Professional Services winstgroei | 15.7% |
Inkomstengroei | 2.1% |
Toekomstig rendement op eigen vermogen | 83.2% |
Dekking van analisten | Good |
Laatst bijgewerkt | 25 Sep 2024 |
Recente toekomstige groei-updates
Recent updates
The Returns At McMillan Shakespeare (ASX:MMS) Aren't Growing
Sep 17McMillan Shakespeare (ASX:MMS) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Sep 02McMillan Shakespeare Limited's (ASX:MMS) 26% Price Boost Is Out Of Tune With Earnings
Feb 23When Should You Buy McMillan Shakespeare Limited (ASX:MMS)?
Oct 25McMillan Shakespeare (ASX:MMS) Has A Pretty Healthy Balance Sheet
Aug 24A Look At The Fair Value Of McMillan Shakespeare Limited (ASX:MMS)
Jun 29We Ran A Stock Scan For Earnings Growth And McMillan Shakespeare (ASX:MMS) Passed With Ease
Jun 15McMillan Shakespeare (ASX:MMS) Is Paying Out A Larger Dividend Than Last Year
Mar 06McMillan Shakespeare (ASX:MMS) Seems To Use Debt Quite Sensibly
Oct 26Calculating The Intrinsic Value Of McMillan Shakespeare Limited (ASX:MMS)
Aug 31Is There Now An Opportunity In McMillan Shakespeare Limited (ASX:MMS)?
Jul 28Is McMillan Shakespeare (ASX:MMS) Using Too Much Debt?
Apr 01Do These 3 Checks Before Buying McMillan Shakespeare Limited (ASX:MMS) For Its Upcoming Dividend
Mar 06McMillan Shakespeare (ASX:MMS) Has Compensated Shareholders With A Respectable 60% Return On Their Investment
Feb 09Do Insiders Own Lots Of Shares In McMillan Shakespeare Limited (ASX:MMS)?
Jan 19Are Insiders Buying McMillan Shakespeare Limited (ASX:MMS) Stock?
Jan 04Is McMillan Shakespeare Limited (ASX:MMS) Trading At A 34% Discount?
Dec 20At AU$11.83, Is McMillan Shakespeare Limited (ASX:MMS) Worth Looking At Closely?
Dec 06Should We Be Cautious About McMillan Shakespeare Limited's (ASX:MMS) ROE Of 1.0%?
Nov 23McMillan Shakespeare Limited (ASX:MMS) Insiders Increased Their Holdings
Sep 13Is Now An Opportune Moment To Examine McMillan Shakespeare Limited (ASX:MMS)?
Aug 25Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
6/30/2027 | 557 | 109 | 141 | 142 | 8 |
6/30/2026 | 534 | 104 | 146 | 137 | 8 |
6/30/2025 | 517 | 92 | 111 | 115 | 8 |
6/30/2024 | 521 | 90 | -128 | -106 | N/A |
3/31/2024 | 501 | 83 | -104 | -83 | N/A |
12/31/2023 | 481 | 76 | -80 | -60 | N/A |
9/30/2023 | 472 | 70 | -36 | -18 | N/A |
6/30/2023 | 464 | 64 | 8 | 25 | N/A |
12/31/2022 | 347 | 69 | 112 | 122 | N/A |
9/30/2022 | 383 | 68 | 111 | 121 | N/A |
6/30/2022 | 419 | 67 | 111 | 120 | N/A |
3/31/2022 | 601 | 68 | 114 | 124 | N/A |
12/31/2021 | 608 | 66 | 118 | 128 | N/A |
9/30/2021 | 576 | 63 | 151 | 162 | N/A |
6/30/2021 | 544 | 61 | 185 | 195 | N/A |
3/31/2021 | 508 | 27 | 221 | 231 | N/A |
12/31/2020 | 471 | -7 | 257 | 266 | N/A |
9/30/2020 | 483 | -3 | 215 | 227 | N/A |
6/30/2020 | 494 | 1 | 174 | 188 | N/A |
3/31/2020 | 520 | 32 | 149 | 166 | N/A |
12/31/2019 | 547 | 64 | 125 | 145 | N/A |
9/30/2019 | 548 | 64 | 119 | 139 | N/A |
6/30/2019 | 550 | 64 | 114 | 133 | N/A |
3/31/2019 | 549 | 57 | 112 | 130 | N/A |
12/31/2018 | 549 | 49 | 111 | 128 | N/A |
9/30/2018 | 547 | 50 | 107 | 123 | N/A |
6/30/2018 | 545 | 50 | 103 | 118 | N/A |
3/31/2018 | 544 | 56 | N/A | 86 | N/A |
12/31/2017 | 542 | 62 | N/A | 53 | N/A |
9/30/2017 | 533 | 65 | N/A | 50 | N/A |
6/30/2017 | 523 | 68 | N/A | 47 | N/A |
3/31/2017 | 518 | 76 | N/A | 52 | N/A |
12/31/2016 | 512 | 84 | N/A | 58 | N/A |
9/30/2016 | 508 | 83 | N/A | 76 | N/A |
6/30/2016 | 505 | 82 | N/A | 95 | N/A |
3/31/2016 | 478 | 79 | N/A | 53 | N/A |
12/31/2015 | 451 | 75 | N/A | 12 | N/A |
9/30/2015 | 420 | 71 | N/A | -2 | N/A |
6/30/2015 | 390 | 67 | N/A | -16 | N/A |
3/31/2015 | 379 | 67 | N/A | 20 | N/A |
12/31/2014 | 369 | 67 | N/A | 56 | N/A |
9/30/2014 | 358 | 61 | N/A | 47 | N/A |
6/30/2014 | 347 | 55 | N/A | 37 | N/A |
3/31/2014 | 339 | 53 | N/A | 37 | N/A |
12/31/2013 | 331 | 52 | N/A | 38 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei MMS ( 5.3% per jaar) ligt boven de spaarquote ( 2.4% ).
Winst versus markt: De winst van MMS ( 5.3% per jaar) zal naar verwachting langzamer groeien dan de markt Australian ( 12.2% per jaar).
Hoge groeiwinsten: De winst van MMS zal naar verwachting groeien, maar niet aanzienlijk.
Omzet versus markt: De omzet van MMS ( 2.1% per jaar) zal naar verwachting langzamer groeien dan de markt Australian ( 5.6% per jaar).
Hoge groei-inkomsten: De omzet van MMS ( 2.1% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen MMS zal naar verwachting over 3 jaar zeer hoog zijn ( 83.2 %).